Maryland Prescription Drug Affordability Board

​Announcements

• UPCOMING MEETING: ​Prescription Drug Affordability Board, Monday, May 18, 2026 at 2:00PM. Meeting information can be found h​e​r​e.
  
• WRITTEN COMMENT REQUESTS: ​Written Comments Requested on the following Documents (Posted 4/22/2026):
• Draft Ozempic Cost Review Study Report- Information can be found here.
• Proposed ​Ozempic: Calculations and Analyses Underpinning Potential UPL Values- Information can be found here. 
• ​​Draft Proposed Regulations- COMAR 14.01.07​.02- Upper Payment Limit for Ozempic - Information can be found h​ere. 
•  All Comments are due Friday, May 1, 2026. ​

• WRITTEN COMMENT REQUEST: Draft Proposed Regulations for Comment (Posted: 5/1/2026): The PDAB is soliciting comments on proposed revisions to COMAR 14.01.04 Cost Review Study Process.​​​ Information can be found he​re.
  
• ​Data Request:  The Maryland Prescription Drug Affordability Board may require covered entities and 340B manufacturers to report information as necessary to complete a study on the implementation, impact, and finances of the 340B program in Maryland, as outlined in 2024 Md. Laws, Chap.​ 962 (HB 1056).  ​Please see the Data request w​ebpage for more information. ​

Join the PDAB Mailing List here​.​
​